World Health Organization (2021) Obesity and overweight. Available at: https://www.who.int/news-room/fact-sheets/detail/obesityand-overweight/. [Accessed Jun. 2, 2023].
Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303:235–41.
Article CAS PubMed Google Scholar
Rodgers A, Woodward A, Swinburn B, Dietz WH. Prevalence trends tell us what did not precipitate the US obesity epidemic. Lancet Public Health. 2018;3:e162–3.
Swinburn BA, Kraak VI, Allender S, Atkins VJ, Baker PI, Bogard JR, et al. The global syndemic of obesity, undernutrition, and climate change: the Lancet Commission report. Lancet. 2019;393:791–846.
Deaths by risk factor in WHO European Region, both sexes, all ages, 2019. In: Viz Hub [website]. Seattle (WA): Institute for Health Metrics and Evaluation; 2021. http://ihmeuw.org/5o2n.
World Health Organization. WHO European Regional Obesity Report 2022. Copenhagen: WHO Regional Office for Europe; 2022.
Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143:E984–1010.
Article PubMed PubMed Central Google Scholar
Ruze R, Liu T, Zou X, Song J, Chen Y, Xu R, et al. Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments. Front Endocrinol. 2023;14:1161521.
Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and cancer: a current overview of epidemiology, pathogenesis, outcomes, and management. Cancers. 2023;15:485.
Cannarella R, Crafa A, Curto R, Condorelli RA, La Vignera S, Calogero AE. Obesity and male fertility disorders. Mol Asp Med. 2024;97:101273.
Dag Z, Dilbaz B. Impact of obesity on infertility in women. J Turk Ger Gynecol Assoc. 2015;16:111–7.
Article PubMed PubMed Central Google Scholar
Lei R, Chen S, Li W. Advances in the study of the correlation between insulin resistance and infertility. Front Endocrinol. 2024;15:1288326.
Leite F, Leite Â, Rasini E, Gaiazzi M, Ribeiro L, Marino F, et al. Dopaminergic pathways in obesity-associated immuno-metabolic depression. Psychol Med. 2018;48:2273–5.
Tai JE, Phillips CL, Yee BJ, Grunstein RR. Obstructive sleep apnoea in obesity: a review. Clin Obes. 2024;14:e12651.
Godziuk K, Hawker GA. Obesity and body mass index: past and future considerations in osteoarthritis research. Osteoarthr Cartil. 2024;32:452–9.
Safaei M, Sundararajan EA, Driss M, Boulila W, Shapi’i A. A systematic literature review on obesity: understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesity. Comput Biol Med. 2021;136:104754.
Wen X, Zhang B, Wu B, Xiao H, Li Z, Li R, et al. Signaling pathways in obesity: mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2022;7:298.
Article PubMed PubMed Central Google Scholar
Lee SJ, Shin SW. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376:1491–2.
Diels S, Vanden Berghe W, Van Hul W. Insights into the multifactorial causation of obesity by integrated genetic and epigenetic analysis. Obes Rev. 2020;21:e13019.
Abdelaal M, le Roux CW, Docherty NG. Morbidity and mortality associated with obesity. Ann Transl Med. 2017;5:161.
Article PubMed PubMed Central Google Scholar
da Silva AA, do Carmo J, Dubinion J, Hall JE. The role of the sympathetic nervous system in obesity-related hypertension. Curr Hypertens Rep. 2009;11:206–11.
Article PubMed PubMed Central Google Scholar
Martinez-Sanchez N, Sweeney O, Sidarta-Oliveira D, Caron A, Stanley SA, Domingos AI. The sympathetic nervous system in the 21st century: neuroimmune interactions in metabolic homeostasis and obesity. Neuron. 2022;110:3597–626.
Article CAS PubMed PubMed Central Google Scholar
Guarino D, Nannipieri M, Iervasi G, Taddei S, Bruno RM. The role of the autonomic nervous system in the pathophysiology of obesity. Front Physiol. 2017;8:665.
Article PubMed PubMed Central Google Scholar
Snitker S, Macdonald I, Ravussin E, Astrup A. The sympathetic nervous system and obesity: role in aetiology and treatment. Obes Rev. 2000;1:5–15.
Article CAS PubMed Google Scholar
Sá Gomes A, Leite F, Ribeiro L. Adipocyte-macrophage crosstalk upon the expression of catecholamine synthesis pathway genes. Mol Biol Cell. 2019;30:3075.
Larabee CM, Neely OC, Domingos AI. Obesity: a neuroimmunometabolic perspective. Nat Rev Endocrinol. 2020;16:30–43.
Euler USv. A specific sympathomimetic ergone in adrenergic nerve fibres (sympathin) and its relations to adrenaline and nor-adrenaline. Acta Physiol Scand. 1946;12:73–97.
Goldstein DS. Adrenaline and noradrenaline. eLS.
Goldstein DS, Eisenhofer G, Kopin IJ. Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharm Exp Ther. 2003;305:800–11.
Tank AW, Lee Wong D. Peripheral and central effects of circulating catecholamines. Compr Physiol. 2015;5:1–15.
Ahlquist RP. A study of the adrenotropic receptors. Am J Physiol. 1948;153:586–600.
Article CAS PubMed Google Scholar
Samanta S, Bagchi D, Bagchi M. Physiological and metabolic functions of the β(3)-adrenergic receptor and an approach to therapeutic achievements. J Physiol Biochem. 2024;80:757–74.
Lafontan M. [Kidney, adipose tissue, adipocytes-what’s new?]. Nephrol Ther. 2011;7:69–79.
Evans BA, Merlin J, Bengtsson T, Hutchinson DS. Adrenoceptors in white, brown, and brite adipocytes. Br J Pharm. 2019;176:2416–32.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Article PubMed PubMed Central Google Scholar
Methley AM, Campbell S, Chew-Graham C, McNally R, Cheraghi-Sohi S. PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res. 2014;14:579.
Article PubMed PubMed Central Google Scholar
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1–253.
Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129:S102–38.
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the Evidence Report. National Institutes of Health. Obes Res. 1998;651s–209s.
Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.
Alberti KG, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469–80.
Article CAS PubMed Google Scholar
Alberti KG, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366:1059–62.
Kmet, L. M., Lee, R. C., & Cook, L. S. Standard Quality Assessment Criteria for Evaluating Primary Research Papersfrom a Variety of Fields (HTA Initiative No. 13). Alberta Heritage Foundation for Medical Research. Retrieved from https://www.ihe.ca/advanced-search/standard-quality-assessment-criteria-for-evaluating-primary-research-papers-from-a-variety-offields. 2004
Crampes F, Marion-Latard F, Zakaroff-Girard A, de Glisezinski I, Harant I, Thalamas C, et al. Effects of a longitudinal training program on responses to exercise in overweight men. Obes Res. 2003;11:247–56.
Comments (0)